Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aptevo Therapeutics Inc. (APVO) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aptevo Therapeutics Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1671584.
Total stock buying since 2017: $24,932,241.
Total stock sales since 2017: $17,242,557.
Total stock option exercises since 2017: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 43 | $0 |
| 2024 | 0 | $0 | 0 | $0 | 8,144 | $0 |
| 2023 | 0 | $0 | 0 | $0 | 71,901 | $0 |
| 2022 | 0 | $0 | 0 | $0 | 9,948 | $0 |
| 2021 | 0 | $0 | 1,760,000 | $16,949,557 | 0 | $0 |
| 2020 | 1,436,675 | $24,398,582 | 0 | $0 | 0 | $0 |
| 2019 | 522,381 | $429,009 | 0 | $0 | 46,830 | $0 |
| 2018 | 15,000 | $35,650 | 100,000 | $293,000 | 171,227 | $0 |
| 2017 | 25,000 | $69,000 | 0 | $0 | 361,852 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 0 | $0 | 26 | $0 |
| 2025-03 | 0 | $0 | 0 | $0 | 17 | $0 |
| 2024-08 | 0 | $0 | 0 | $0 | 685 | $0 |
| 2024-05 | 0 | $0 | 0 | $0 | 42 | $0 |
| 2024-01 | 0 | $0 | 0 | $0 | 7,417 | $0 |
| 2023-08 | 0 | $0 | 0 | $0 | 47,987 | $0 |
| 2023-06 | 0 | $0 | 0 | $0 | 4,455 | $0 |
| 2023-05 | 0 | $0 | 0 | $0 | 5,502 | $0 |
| 2023-03 | 0 | $0 | 0 | $0 | 7,332 | $0 |
| 2023-01 | 0 | $0 | 0 | $0 | 6,625 | $0 |
| 2022-06 | 0 | $0 | 0 | $0 | 3,323 | $0 |
| 2022-01 | 0 | $0 | 0 | $0 | 6,625 | $0 |
| 2021-11 | 0 | $0 | 1,760,000 | $16,949,557 | 0 | $0 |
| 2020-11 | 1,436,675 | $24,398,582 | 0 | $0 | 0 | $0 |
| 2019-08 | 125,000 | $94,500 | 0 | $0 | 0 | $0 |
| 2019-07 | 200,000 | $172,710 | 0 | $0 | 0 | $0 |
| 2019-06 | 127,381 | $107,129 | 0 | $0 | 0 | $0 |
| 2019-05 | 70,000 | $54,670 | 0 | $0 | 0 | $0 |
| 2019-03 | 0 | $0 | 0 | $0 | 46,830 | $0 |
| 2018-12 | 15,000 | $35,650 | 0 | $0 | 0 | $0 |
| 2018-08 | 0 | $0 | 0 | $0 | 1,630 | $0 |
| 2018-05 | 0 | $0 | 0 | $0 | 35,644 | $0 |
| 2018-03 | 0 | $0 | 100,000 | $293,000 | 63,096 | $0 |
| 2018-02 | 0 | $0 | 0 | $0 | 70,857 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-17 | Kwon Soyoung (SVP, GC, BD & Corp Affairs) | Option Ex | 3 | .00 | 0 |
| 2025-07-17 | Kunz Barbara Lopez | Option Ex | 1 | .00 | 0 |
| 2025-07-17 | Lamothe Jeffrey G. (EVP, COO) | Option Ex | 5 | .00 | 0 |
| 2025-07-17 | Grant Grady Iii | Option Ex | 1 | .00 | 0 |
| 2025-07-17 | Niederhuber John | Option Ex | 1 | .00 | 0 |
| 2025-07-17 | White Marvin L (President and CEO) | Option Ex | 10 | .00 | 0 |
| 2025-07-17 | Taylor Daphne (SVP, CFO) | Option Ex | 3 | .00 | 0 |
| 2025-07-17 | Abdun-nabi Daniel | Option Ex | 1 | .00 | 0 |
| 2025-07-17 | Harsanyi Zsolt | Option Ex | 1 | .00 | 0 |
| 2025-03-04 | Taylor Daphne (SVP, CFO) | Option Ex | 1 | .00 | 0 |
| 2025-03-03 | White Marvin L (President and CEO) | Option Ex | 6 | .00 | 0 |
| 2025-03-02 | White Marvin L (President and CEO) | Option Ex | 8 | .00 | 0 |
| 2025-03-02 | Taylor Daphne (SVP, CFO) | Option Ex | 2 | .00 | 0 |
| 2024-08-08 | Kwon Soyoung (SVP, GC, BD & Corp Affairs) | Option Ex | 213 | .00 | 0 |
| 2024-08-08 | Lamothe Jeffrey G. (EVP, COO) | Option Ex | 314 | .00 | 0 |
| 2024-08-08 | Taylor Daphne (SVP, CFO) | Option Ex | 158 | .00 | 0 |
| 2024-05-31 | Kwon Soyoung (SVP, GC, BD & Corp Affairs) | Option Ex | 42 | .00 | 0 |
| 2024-01-29 | Taylor Daphne (SVP, CFO) | Option Ex | 792 | .00 | 0 |
| 2024-01-28 | Lamothe Jeffrey G. (EVP, COO) | Option Ex | 1,833 | .00 | 0 |
| 2024-01-28 | White Marvin L (President and CEO) | Option Ex | 4,792 | .00 | 0 |
| 2023-08-09 | Kunz Barbara Lopez (Director) | Option Ex | 3,571 | .00 | 0 |
| 2023-08-09 | Grant Grady Iii (Director) | Option Ex | 3,571 | .00 | 0 |
| 2023-08-09 | Niederhuber John (Director) | Option Ex | 3,571 | .00 | 0 |
| 2023-08-09 | Abdun-nabi Daniel (Director) | Option Ex | 3,571 | .00 | 0 |
| 2023-08-09 | Harsanyi Zsolt (Director) | Option Ex | 3,571 | .00 | 0 |
| 2023-08-08 | Kwon Soyoung (SVP, GC, BD & Corp Affairs) | Option Ex | 9,375 | .00 | 0 |
| 2023-08-08 | Lamothe Jeffrey G. (EVP, COO) | Option Ex | 13,812 | .00 | 0 |
| 2023-08-08 | Taylor Daphne (SVP, CFO) | Option Ex | 6,945 | .00 | 0 |
| 2023-06-01 | Kunz Barbara Lopez (Director) | Option Ex | 594 | .00 | 0 |
| 2023-06-01 | Grant Grady Iii (Director) | Option Ex | 594 | .00 | 0 |
| 2023-06-01 | Niederhuber John (Director) | Option Ex | 594 | .00 | 0 |
| 2023-06-01 | Abdun-nabi Daniel (Director) | Option Ex | 594 | .00 | 0 |
| 2023-06-01 | Harsanyi Zsolt (Director) | Option Ex | 594 | .00 | 0 |
| 2023-05-31 | Kwon Soyoung (SVP, GC, BD & Corp Affairs) | Option Ex | 3,668 | .00 | 0 |
| 2023-03-03 | Kwon Soyoung (SVP, GC, BD & Corp Affairs) | Option Ex | 3,666 | .00 | 0 |
| 2023-03-03 | Lamothe Jeffrey G. (EVP, COO) | Option Ex | 3,666 | .00 | 0 |
| 2023-01-29 | Lamothe Jeffrey G. (CFO) | Option Ex | 1,834 | .00 | 0 |
| 2023-01-29 | White Marvin L (President and CEO) | Option Ex | 4,791 | .00 | 0 |
| 2022-06-01 | Kwon Soyoung (SVP, GC and Corporate Affairs) | Option Ex | 1,833 | .00 | 0 |
| 2022-06-01 | Kunz Barbara Lopez (Director) | Option Ex | 298 | .00 | 0 |
| 2022-06-01 | Grant Grady Iii (Director) | Option Ex | 298 | .00 | 0 |
| 2022-06-01 | Niederhuber John (Director) | Option Ex | 298 | .00 | 0 |
| 2022-06-01 | Abdun-nabi Daniel (Director) | Option Ex | 298 | .00 | 0 |
| 2022-06-01 | Harsanyi Zsolt (Director) | Option Ex | 298 | .00 | 0 |
| 2022-01-29 | Lamothe Jeffrey G. (SVP and CFO) | Option Ex | 1,833 | .00 | 0 |
| 2022-01-29 | White Marvin L (President and CEO) | Option Ex | 4,792 | .00 | 0 |
| 2021-11-23 | Tang Capital Partners Lp (Other) | Sale | 921,336 | 11.29 | 10,399,119 |
| 2021-11-22 | Tang Capital Partners Lp (10% Owner) | Sale | 255,331 | 6.92 | 1,767,145 |
| 2021-11-19 | Tang Capital Partners Lp (10% Owner) | Sale | 213,800 | 7.77 | 1,660,370 |
| 2021-11-18 | Tang Capital Partners Lp (10% Owner) | Sale | 369,533 | 8.45 | 3,122,923 |
| 2020-11-06 | Tang Capital Partners Lp (10% Owner) | Buy | 174,277 | 22.58 | 3,934,826 |
| 2020-11-05 | Tang Capital Partners Lp (10% Owner) | Buy | 625,723 | 18.39 | 11,508,923 |
| 2020-11-04 | Tang Capital Partners Lp (10% Owner) | Buy | 636,675 | 14.06 | 8,954,833 |
| 2019-08-16 | Maddux Randy Joe (SVP Operations, CMO) | Buy | 25,000 | .76 | 19,000 |
| 2019-08-12 | El-hibri Fuad | Buy | 100,000 | .76 | 75,500 |
| 2019-07-29 | El-hibri Fuad (Board of Directors) | Buy | 55,015 | .83 | 45,882 |
| 2019-07-23 | El-hibri Fuad (Board of Directors) | Buy | 10,000 | .90 | 9,000 |
| 2019-07-22 | El-hibri Fuad (Board of Directors) | Buy | 30,000 | .89 | 26,610 |
| 2019-07-19 | El-hibri Fuad (Board of Directors) | Buy | 26,460 | .90 | 23,734 |
| 2019-07-18 | El-hibri Fuad (Board of Directors) | Buy | 14,404 | .88 | 12,603 |
| 2019-07-17 | El-hibri Fuad (Board of Directors) | Buy | 19,136 | .87 | 16,705 |
| 2019-07-16 | El-hibri Fuad (Board of Directors) | Buy | 11,375 | .85 | 9,657 |
| 2019-07-11 | El-hibri Fuad (Board of Directors) | Buy | 14,691 | .85 | 12,457 |
| 2019-07-10 | El-hibri Fuad | Buy | 18,919 | .85 | 16,062 |
| 2019-06-25 | Abdun-nabi Daniel (Board of Directors) | Buy | 16,667 | .90 | 15,000 |
| 2019-06-14 | Niederhuber John (Director) | Buy | 714 | .91 | 649 |
| 2019-06-14 | White Marvin L (President and CEO) | Buy | 50,000 | .88 | 44,000 |
| 2019-06-10 | Kunz Barbara Lopez (Board of Directors) | Buy | 10,000 | .85 | 8,480 |
| 2019-06-07 | Harsanyi Zsolt (Board of Directors) | Buy | 50,000 | .78 | 39,000 |
| 2019-05-31 | Maddux Randy Joe (Senior VP, Operations) | Buy | 20,000 | .73 | 14,600 |
| 2019-05-21 | Grant Grady Iii (Board of Directors) | Buy | 10,000 | .80 | 7,970 |
| 2019-05-20 | White Marvin L (President and CEO) | Buy | 30,000 | .81 | 24,300 |
| 2019-05-14 | White Marvin L (President and CEO) | Buy | 10,000 | .78 | 7,800 |
| 2019-03-01 | Adelman Michael (SVP, Commercial Operations) | Option Ex | 7,318 | .00 | 0 |
| 2019-03-01 | Mitchell Shawnte (SVP, GC and Corporate Affairs) | Option Ex | 6,787 | .00 | 0 |
| 2019-03-01 | Gross Jane A (See Remarks) | Option Ex | 9,138 | .00 | 0 |
| 2019-03-01 | Stromatt Scott C (Chief Medical Officer and SVP) | Option Ex | 16,269 | .00 | 0 |
| 2019-03-01 | Lamothe Jeffrey G. (SVP and CFO) | Option Ex | 7,318 | .00 | 0 |
| 2018-12-06 | Maddux Randy Joe (SVP Operations) | Buy | 5,000 | 2.37 | 11,850 |
| 2018-12-04 | White Marvin L (President and CEO) | Buy | 10,000 | 2.38 | 23,800 |
| 2018-08-09 | Mitchell Shawnte (SVP, GC and Corporate Affairs) | Option Ex | 1,630 | .00 | 0 |
| 2018-05-21 | White Marvin L (President and CEO) | Option Ex | 35,644 | .00 | 0 |
| 2018-03-19 | White Marvin L (President and CEO) | Sale | 100,000 | 2.93 | 293,000 |
| 2018-03-10 | Lamothe Jeffrey G. (SVP, CFO and Treasurer) | Option Ex | 6,747 | .00 | 0 |
| 2018-03-09 | Gross Jane A (See Remarks) | Option Ex | 9,728 | .00 | 0 |
| 2018-03-09 | Stromatt Scott C (Chief Medical Officer and SVP) | Option Ex | 13,892 | .00 | 0 |
| 2018-03-01 | Gross Jane A (See Remarks) | Option Ex | 9,140 | .00 | 0 |
| 2018-03-01 | Stromatt Scott C (Chief Medical Officer and SVP) | Option Ex | 16,269 | .00 | 0 |
| 2018-03-01 | Lamothe Jeffrey G. (SVP, CFO and Treasurer) | Option Ex | 7,320 | .00 | 0 |
| 2018-02-03 | Gross Jane A (See Remarks) | Option Ex | 18,136 | .00 | 0 |
| 2018-02-03 | Stromatt Scott C (Chief Medical Officer and SVP) | Option Ex | 27,381 | .00 | 0 |
| 2018-02-03 | Lamothe Jeffrey G. (SVP, CFO and Treasurer) | Option Ex | 25,340 | .00 | 0 |
| 2017-11-15 | Maddux Randy Joe (Senior VP, Operations) | Buy | 25,000 | 2.76 | 69,000 |
| 2017-08-01 | Gross Jane A (See Remarks) | Option Ex | 38,093 | .00 | 0 |
| 2017-08-01 | Stromatt Scott C (Chief Medical Officer and SVP) | Option Ex | 78,123 | .00 | 0 |
| 2017-05-22 | White Marvin L (President and CEO) | Option Ex | 53,471 | .00 | 0 |
| 2017-03-10 | Gross Jane A (See Remarks) | Option Ex | 14,506 | .00 | 0 |
| 2017-03-10 | Stromatt Scott C (Chief Medical Officer and SVP) | Option Ex | 24,836 | .00 | 0 |
| 2017-03-10 | Lamothe Jeffrey G. (SVP, CFO and Treasurer) | Option Ex | 18,863 | .00 | 0 |
| 2017-03-09 | Gross Jane A (See Remarks) | Option Ex | 9,727 | .00 | 0 |
| 2017-03-09 | Stromatt Scott C (Chief Medical Officer and SVP) | Option Ex | 13,902 | .00 | 0 |
| 2017-03-01 | Gross Jane A (See Remarks) | Option Ex | 9,140 | .00 | 0 |
| 2017-03-01 | Stromatt Scott C (Chief Medical Officer and SVP) | Option Ex | 16,269 | .00 | 0 |
| 2017-03-01 | Lamothe Jeffrey G. (SVP, CFO and Treasurer) | Option Ex | 14,066 | .00 | 0 |
| 2017-02-03 | Gross Jane A (See Remarks) | Option Ex | 18,135 | .00 | 0 |
| 2017-02-03 | Stromatt Scott C (Chief Medical Officer and SVP) | Option Ex | 27,381 | .00 | 0 |
| 2017-02-03 | Lamothe Jeffrey G. (SVP, CFO and Treasurer) | Option Ex | 25,340 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of APVO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aptevo Therapeutics Inc. (symbol APVO, CIK number 1671584) see the Securities and Exchange Commission (SEC) website.